SCHEMBL6556448

SCHEMBL6556448

CCCS(=O)(=O)Oc1cc(Cc2cnc(N)nc2N)cc(OCC)c1-c1ccc2c(c1)OCO2

nearest known ligand 0.56

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DHFR P00374 3/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6556518 0.91 DHFR (0.59) DHFR
SCHEMBL6555369 0.89 DHFR (0.69) DHFR
SCHEMBL6555086 0.88 DHFR (0.56) DHFR
SCHEMBL6555728 0.85 DHFR (0.49) DHFR
SCHEMBL6555195 0.85 DHFR (0.63) DHFR
SCHEMBL6555396 0.85 DHFR (0.61) DHFR
SCHEMBL6555132 0.84 DHFR (0.49) DHFR
SCHEMBL6556512 0.84 DHFR (0.59) DHFR
SCHEMBL6555773 0.84 DHFR (0.61) DHFR
SCHEMBL6555416 0.83 DHFR (0.60) DHFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1230224-B1 SUBSTITUTED 5-BENZYL-2,4-DIAMINOPYRIMIDINES BASILEA PHARMACEUTICA AG (CH) 2004-12-29 EP disclosed
US-6821980-B1 Substituted 5-benzyl-2,4-diaminopyrimidines BASILEA PHARMACEUTICA AG (CH) 2004-11-23 US disclosed
EP-1230224-A1 SUBSTITUTED 5-BENZYL-2,4-DIAMINOPYRIMIDINES F. HOFFMANN-LA ROCHE AG (CH) 2002-08-14 EP disclosed
WO-2001032633-A1 SUBSTITUTED 5-BENZYL-2,4-DIAMINOPYRIMIDINES BASILEA PHARMACEUTICA AG (CH) 2001-05-10 WO disclosed